Byoung Kook Kim

1.7k total citations
70 papers, 1.1k citations indexed

About

Byoung Kook Kim is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Byoung Kook Kim has authored 70 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 28 papers in Molecular Biology and 16 papers in Oncology. Recurrent topics in Byoung Kook Kim's work include Gut microbiota and health (14 papers), Acute Myeloid Leukemia Research (12 papers) and Hematopoietic Stem Cell Transplantation (9 papers). Byoung Kook Kim is often cited by papers focused on Gut microbiota and health (14 papers), Acute Myeloid Leukemia Research (12 papers) and Hematopoietic Stem Cell Transplantation (9 papers). Byoung Kook Kim collaborates with scholars based in South Korea, Ethiopia and United States. Byoung Kook Kim's co-authors include Jae Goo Seol, Chul Won Jung, Seonyang Park, Byung‐Yong Kim, Young Yiul Lee, Ki Tae Suk, Sung‐Soo Yoon, Tae‐Sik Park, Sang Jun Yoon and Inho Kim and has published in prestigious journals such as Blood, Cancer Research and Scientific Reports.

In The Last Decade

Byoung Kook Kim

70 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Byoung Kook Kim South Korea 20 507 226 206 184 178 70 1.1k
Kamal Ivory United Kingdom 20 374 0.7× 457 2.0× 204 1.0× 136 0.7× 97 0.5× 37 1.6k
Emmanuel Mas France 19 318 0.6× 60 0.3× 218 1.1× 148 0.8× 72 0.4× 70 1.3k
Makoto Shioya Japan 17 544 1.1× 53 0.2× 176 0.9× 311 1.7× 78 0.4× 36 1.5k
Lu Jiang China 14 446 0.9× 108 0.5× 228 1.1× 62 0.3× 109 0.6× 45 814
David Oliveira United Kingdom 26 290 0.6× 64 0.3× 212 1.0× 65 0.4× 96 0.5× 89 2.1k
Faris Q Alenzi Saudi Arabia 17 325 0.6× 68 0.3× 130 0.6× 106 0.6× 95 0.5× 70 1.1k
Ton Naber Netherlands 20 276 0.5× 49 0.2× 186 0.9× 76 0.4× 57 0.3× 38 1.4k
Tomomi Sato Japan 16 190 0.4× 53 0.2× 104 0.5× 154 0.8× 148 0.8× 58 946
Philip W. Peake Australia 28 359 0.7× 110 0.5× 530 2.6× 71 0.4× 61 0.3× 62 1.7k
Xiaohuan Guo China 22 1.1k 2.2× 77 0.3× 143 0.7× 491 2.7× 134 0.8× 61 3.0k

Countries citing papers authored by Byoung Kook Kim

Since Specialization
Citations

This map shows the geographic impact of Byoung Kook Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Byoung Kook Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Byoung Kook Kim more than expected).

Fields of papers citing papers by Byoung Kook Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Byoung Kook Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Byoung Kook Kim. The network helps show where Byoung Kook Kim may publish in the future.

Co-authorship network of co-authors of Byoung Kook Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Byoung Kook Kim. A scholar is included among the top collaborators of Byoung Kook Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Byoung Kook Kim. Byoung Kook Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Won‐Kyung, et al.. (2023). Protective effect of the mixture of Lactiplantibacillus plantarum KC3 and Leonurus Japonicas Houtt extract on respiratory disorders. Ecotoxicology and Environmental Safety. 270. 115856–115856. 2 indexed citations
2.
Lee, Na Young, Ki‐Kwang Oh, Haripriya Gupta, et al.. (2023). Gut Lactobacillus and Probiotics Lactobacillus lactis/rhamnosis Ameliorate Liver Fibrosis in Prevention and Treatment. The Journal of Microbiology. 61(2). 245–257. 10 indexed citations
3.
Yoon, Sang Jun, Byeong Hyun Min, Haripriya Gupta, et al.. (2023). Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis. Frontiers in Microbiology. 14. 1129904–1129904. 52 indexed citations
4.
Chun, Byung Hee, et al.. (2021). Safety Assessment of Lactiplantibacillus (formerly Lactobacillus) plantarum Q180. Journal of Microbiology and Biotechnology. 31(10). 1420–1429. 19 indexed citations
5.
Kim, Byoung Kook, et al.. (2021). Taxonomic profiling of skin microbiome and correlation with clinical skin parameters in healthy Koreans. Scientific Reports. 11(1). 16269–16269. 43 indexed citations
6.
Lee, Na Young, et al.. (2020). Lactobacillus lactis CKDB001 ameliorate progression of nonalcoholic fatty liver disease through of gut microbiome: addendum. Gut Microbes. 12(1). 1829449–1829449. 11 indexed citations
7.
Lee, Na Young, Sang Jun Yoon, Dae Hee Han, et al.. (2020). LactobacillusandPediococcusameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiome. Gut Microbes. 11(4). 882–899. 95 indexed citations
8.
Lee, Chul Sang, et al.. (2020). Prevention of bone loss by using Lactobacillus-fermented milk products in a rat model of glucocorticoid-induced secondary osteoporosis. International Dairy Journal. 109. 104788–104788. 11 indexed citations
9.
Lee, Na Young, Min Jea Shin, Gi Soo Youn, et al.. (2020). <i>Lactobacillus</i> attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis. Clinical and Molecular Hepatology. 27(1). 110–124. 94 indexed citations
10.
Kim, Byoung Kook, In Suk Choi, Jihee Kim, et al.. (2017). Effects of Fermented Milk with Mixed Strains as a Probiotic on the Inhibition of Loperamide-Induced Constipation.. Europe PMC (PubMed Central). 37(6). 906–916. 7 indexed citations
11.
Shin, Dong‐Yeop, Yoon Kyung Jeon, Tae Min Kim, et al.. (2011). Clinical dissection of multicentric Castleman disease. Leukemia & lymphoma. 52(8). 1517–1522. 34 indexed citations
12.
13.
Koh, Youngil, Inho Kim, Soo‐Mee Bang, et al.. (2009). Non-A type nucleophosmin 1 gene mutation predicts poor clinical outcome in de novo adult acute myeloid leukemia: differential clinical importance of NPM1 mutation according to subtype. International Journal of Hematology. 90(1). 1–5. 19 indexed citations
14.
15.
Kim, Tae Min, Jin Soo Kim, Yong Sang Hong, et al.. (2008). Clinical predictors of recurrent venous thromboembolism: A single institute experience in Korea. Thrombosis Research. 123(3). 436–443. 23 indexed citations
16.
Lee, Keun‐Wook, Tak Yun, Im Il Na, et al.. (2005). A Pilot Study of Bortezomib in Korean Patients with Relapsed or Refractory Myeloma. Journal of Korean Medical Science. 20(4). 598–598. 4 indexed citations
17.
Kim, Young Ju, et al.. (2005). Effect of the combination of imatinib mesylate (Glivec) and curcumin in chronic myeloid leukemia cell line. Cancer Research. 65. 1208–1209. 2 indexed citations
18.
Kim, Daeyoung, Jee Hyun Kim, Young Joo Park, et al.. (2004). Case of complete recovery of pancytopenia after treatment of hypopituitarism. Annals of Hematology. 83(5). 309–312. 19 indexed citations
19.
Kim, Youngju, Kwang‐Sung Ahn, Jong-Seok Lee, et al.. (2004). Effect of the Combination of Imatinib Mesylate (Glivec) and Curcumin in Chronicm Myeloid Leukemia Cell Line.. Blood. 104(11). 4685–4685. 1 indexed citations
20.
Park, Seonyang, et al.. (1985). A Study on Thrombokinetics In Korean Hemorrhagic Fever. Seoul National University Open Repository (Seoul National University). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kamal Ivory Breakdown of academic impact, for papers by Emmanuel Mas Breakdown of academic impact, for papers by Makoto Shioya Breakdown of academic impact, for papers by Lu Jiang Breakdown of academic impact, for papers by David Oliveira Breakdown of academic impact, for papers by Faris Q Alenzi Breakdown of academic impact, for papers by Ton Naber Breakdown of academic impact, for papers by Tomomi Sato Breakdown of academic impact, for papers by Philip W. Peake Breakdown of academic impact, for papers by Xiaohuan Guo
Rankless by CCL
2026